Trials / Active Not Recruiting
Active Not RecruitingNCT04757753
Root Canal Obturation With a Ready-to-use Root Canal Sealer (PA1704) Versus BioRoot™ RCS: a Randomized Controlled Trial
Evaluation of the Efficacy Rate of Endodontic Treatment at 2 Years After Root Canal Filling With a Ready-to-use Root Canal Sealer PA1704 Versus BioRoot™ RCS: a Randomized Controlled Trial
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Septodont · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study design is a multicentric randomized controlled non-inferiority trial. 160 subjects (teeth) requiring a primary or a secondary root canal treatment will be enrolled in 2 groups (80 in each group). The aim of the study is to assess the efficacy rate and the safety 2 years after root canal obturation undertaken using a ready-to-use calcium silicate sealer (PA1704) compared to the control calcium silicate sealer BioRoot™ RCS. Procedures of root canal treatment will be conventional and standardized for all investigational centers. The canals will be cleaned, shaped and then obturated using a calcium silicate sealer (the ready to use sealer PA1704 or BioRoot™ RCS) with a single cone technique or cold lateral condensation of gutta-percha. Follow-up assessments will be conducted at 6, 12 and 24 months in both groups. The performance and safety of the sealer PA1704 will also be evaluated at 3.5 and 5 years after surgery. Retroalveolar radiographs will be taken at each study visit. The preoperative, postoperative and follow-up clinical and radiographic data will be analyzed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ready-to-use root canal sealer: PA1704 | The participant will be treated with the ready-to-use root canal sealer (PA1704) in combination with gutta percha. |
| DEVICE | root canal sealer: BioRoot™ RCS | The participant will be treated with BioRoot™ RCS sealer in combination with gutta percha. |
Timeline
- Start date
- 2020-11-06
- Primary completion
- 2023-08-29
- Completion
- 2026-07-01
- First posted
- 2021-02-17
- Last updated
- 2025-06-26
- Results posted
- 2024-10-10
Locations
5 sites across 2 countries: Belgium, France
Source: ClinicalTrials.gov record NCT04757753. Inclusion in this directory is not an endorsement.